Treatment
Medical Care
No local or systemic medical treatment is available to stop the progression of corneal lipid deposition or the alteration of serum cholesterol levels.
Next:
Surgical Care
Penetrating keratoplasty (PKP) can be performed successfully in those patients with advanced disease, but the dystrophy can recur in the graft. One study showed recurrence in 21% of eyes who underwent PKP. [3]
Phototherapeutic keratectomy can remove subepithelial crystals if they are causing decreased vision and glare, but it does not reduce panstromal haze. [6]
Previous
Next:
Long-Term Monitoring
Patients should receive follow-up care as needed.
Previous
Media Gallery
-
A 22-year-old woman with circular corneal opacity best seen in retroillumination. Weiss JS: Schnyder's dystrophy of the cornea: a Swede-Finn connection. Cornea 1992; 11(2): 93-101.
-
A 20-year-old woman with ringlike deposition of anterior stromal cholesterol crystals. Weiss JS: Schnyder's dystrophy of the cornea: a Swede-Finn connection. Cornea 1992; 11(2): 93-101.
-
A 37-year-old man with central disclike opacity, affecting the entire stromal thickness, anterior stromal cholesterol crystals, and peripheral arcus lipoides. Weiss JS: Schnyder's dystrophy of the cornea: a Swede-Finn connection. Cornea 1992; 11(2): 93-101.
-
A 78-year-old woman with dense arcus lipoides in the corneal periphery, sparing the corneal scleral limbus. Weiss JS: Schnyder's dystrophy of the cornea: a Swede-Finn connection. Cornea 1992; 11(2): 93-101.
-
The natural history of Schnyder dystrophy with age. Weiss JS: Schnyder's dystrophy of the cornea: a Swede-Finn connection. Cornea 1992; 11(2): 93-101.
of
5